Literature DB >> 33665194

Gallium-68 Ventilation/Perfusion PET-CT and CT Pulmonary Angiography for Pulmonary Embolism Diagnosis: An Interobserver Agreement Study.

Romain Le Pennec1, Amir Iravani2, Beverley Woon2, Brieg Dissaux3, Bibiche Gest2, Pierre-Yves Le Floch3, Pierre-Yves Salaün2, Grégoire Le Gal4, Michael S Hofman2,5, Rodney J Hicks2,5, Pierre-Yves Le Roux1,2.   

Abstract

Objectives: 68Ga Ventilation/Perfusion V/Q PET-CT is a promising imaging tool for pulmonary embolism diagnosis. However, no study has verified whether the interpretation is reproducible between different observers. The aim of this study was to assess the interobserver agreement in the interpretation of V/Q PET-CT for the diagnosis of acute PE, and to compare it to the interobserver agreement of CTPA interpretation.
Methods: Twenty-four cancer patients with suspected acute PE underwent V/Q PET-CT and CTPA within 24 h as part of a prospective pilot study evaluating V/Q PET-CT for the management of patients with suspected PE. V/Q PET-CT and CTPA scans were reassessed independently by four nuclear medicine physicians and four radiologists, respectively. Physicians had different levels of expertise in reading V/Q scintigraphy and CTPA. Interpretation was blinded to the initial interpretation and any clinical information or imaging test result. For each modality, results were reported on a binary fashion. V/Q PET/CT scans were read as positive if there was at least one segmental or two subsegmental mismatched perfusion defects. CTPA scans were interpreted as positive if there was a constant intraluminal filling defect. Interobserver agreement was assessed by calculating kappa (κ) coefficients.
Results: Out of the 24 V/Q PET-CT scans, the diagnostic conclusion was concordantly negative in 22 patients and concordantly positive in one patient. The remaining scan was interpreted as positive by one reader and negative by three readers. Out of the 24 CTPA scans, the diagnostic conclusion was concordantly negative in 16 and concordantly positive in one. Out of the seven remaining scans, PE was reported by one reader in four cases, by two readers in two cases, by three readers in one case. Most of discordant results on CTPA were related to clots reported on subsegmental arteries. Mean kappa coefficient was 0.79 for V/Q PET-CT interpretation and 0.39 for CTPA interpretation. Conclusions: Interobserver agreement in the interpretation of V/Q PET-CT for PE diagnosis was substantial (kappa 0.79) in a population with a low prevalence of significant PE. Agreement was lower with CTPA, mainly as a result of discrepancies at the level of the subsegmental arteries.
Copyright © 2021 Le Pennec, Iravani, Woon, Dissaux, Gest, Le Floch, Salaün, Le Gal, Hofman, Hicks and Le Roux.

Entities:  

Keywords:  CTPA (computed tomography pulmonary angiography); V/Q PET/CT; V/Q pulmonary imaging; interobservator variability; interobserver agreement

Year:  2021        PMID: 33665194      PMCID: PMC7921798          DOI: 10.3389/fmed.2020.599901

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  32 in total

1.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors:  D W BARRITT; S C JORDAN
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

2.  Difference in interpretation of computed tomography pulmonary angiography diagnosis of subsegmental thrombosis in patients with suspected pulmonary embolism.

Authors:  E Pena; M Kimpton; C Dennie; R Peterson; G LE Gal; M Carrier
Journal:  J Thromb Haemost       Date:  2012-03       Impact factor: 5.824

3.  Additional value of combining low-dose computed tomography to V/Q SPECT on a hybrid SPECT-CT camera for pulmonary embolism diagnosis.

Authors:  Pierre-Yves Le Roux; Philippe Robin; Aurélien Delluc; Ronan Abgral; Xavier Palard; Valentin Tissot; Agnes Morel; Jean Rousset; Francis Couturaud; Grégoire le Gal; Pierre-Yves Salaun
Journal:  Nucl Med Commun       Date:  2015-09       Impact factor: 1.690

4.  Pulmonary embolism diagnosis and mortality with pulmonary CT angiography versus ventilation-perfusion scintigraphy: evidence of overdiagnosis with CT?

Authors:  Steven H Sheh; Eran Bellin; Katherine D Freeman; Linda B Haramati
Journal:  AJR Am J Roentgenol       Date:  2012-06       Impact factor: 3.959

Review 5.  How to Assess Quality of Primary Research Studies in the Medical Literature?

Authors:  Grégoire Le Gal; Pierre-Yves Le Roux
Journal:  Semin Nucl Med       Date:  2018-12-05       Impact factor: 4.446

6.  Pulmonary Scintigraphy for the Diagnosis of Acute Pulmonary Embolism: A Survey of Current Practices in Australia, Canada, and France.

Authors:  Pierre-Yves Le Roux; Matthieu Pelletier-Galarneau; Romain De Laroche; Michael S Hofman; Lionel S Zuckier; Paul Roach; Jean-Philippe Vuillez; Rodney J Hicks; Grégoire Le Gal; Pierre-Yves Salaun
Journal:  J Nucl Med       Date:  2015-07-01       Impact factor: 10.057

7.  Prospective evaluation of the negative predictive value of V/Q SPECT using 99mTc-Technegas.

Authors:  Michel Leblanc; Félix Leveillée; Eric Turcotte
Journal:  Nucl Med Commun       Date:  2007-08       Impact factor: 1.690

8.  EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond.

Authors:  Marika Bajc; Carl Schümichen; Thomas Grüning; Ari Lindqvist; Pierre-Yves Le Roux; Adriano Alatri; Ralf W Bauer; Mirza Dilic; Brian Neilly; Hein J Verberne; Roberto C Delgado Bolton; Bjorn Jonson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-13       Impact factor: 9.236

9.  Gallium-68 perfusion positron emission tomography/computed tomography to assess pulmonary function in lung cancer patients undergoing surgery.

Authors:  Pierre-Yves Le Roux; Tracy L Leong; Stephen A Barnett; Rodney J Hicks; Jason Callahan; Peter Eu; Renee Manser; Michael S Hofman
Journal:  Cancer Imaging       Date:  2016-08-20       Impact factor: 3.909

10.  Automatic delineation of functional lung volumes with 68Ga-ventilation/perfusion PET/CT.

Authors:  Pierre-Yves Le Roux; Shankar Siva; Jason Callahan; Yannis Claudic; David Bourhis; Daniel P Steinfort; Rodney J Hicks; Michael S Hofman
Journal:  EJNMMI Res       Date:  2017-10-10       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.